Elevance Health ELV reported its Q2 earnings results on Wednesday, July 20, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Elevance Health beat estimated earnings by 3.88%, reporting an EPS of $8.04 versus an estimate of $7.74.
Revenue was up $5.20 billion from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.44 which was followed by a 1.32% drop in the share price the next day.
Here's a look at Elevance Health's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | 7.81 | 5.11 | 6.39 | 6.33 |
EPS Actual | 8.25 | 5.14 | 6.79 | 7.03 |
Revenue Estimate | 37.42B | 36.51B | 35.30B | 33.21B |
Revenue Actual | 37.89B | 36.02B | 35.55B | 33.28B |
To track all earnings releases for Elevance Health visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.